Terpinolene, a component of herbal sage, downregulates AKT1 expression in K562 cells

  • Authors: Naoko Okumura, Hitomi Yoshida, Yuri Nishimura, Yasuko Kitagishi, Satoru Matsuda
  • View Affiliations

  • Published online on: Friday, November 18, 2011
  • Pages: 321-324
  • DOI: 10.3892/ol.2011.491

Abstract

Protein kinase AKT mediates cell proliferation and survival signals, and also contributes to cancer progression. Increased expression and/or activation of AKT is involved in a variety of human cancers. In cells treated with sage or rosemary extract, mRNA and protein expression levels of AKT1 were reduced compared with those of the control cells 48 h after the herbal treatments. We found that terpinolene, a common component of sage and rosemary, markedly reduced the protein expression of AKT1 in K562 cells and inhibited cell proliferation.

Introduction

The serine/threonine protein kinase AKT (also known as protein kinase B) mediates the cell survival signals coming through the phosphoinositide 3-kinase (PI3K) pathway by phosphorylation (1,2). Human AKT has three isoforms: AKT1, AKT2 and AKT3. Once activated, AKT moves to the cytoplasm and nucleus, where it phosphorylates, activates or inhibits numerous downstream targets to regulate various cellular functions, including cell proliferation. Increased expression and activation of AKT is involved in a variety of human cancers. Although the activation of AKT alone is believed to be insufficient for tumorigenesis, it contributes to cancer progression by inhibiting apoptosis, promoting the cell proliferation and regulating their invasion abilities. Accordingly, AKT inhibitors are now in clinical development for the treatment of cancers (3).

Certain herbs are believed to possess numerous beneficial activities. The clinical use of herbal medications in therapy is widespread as herbs have mild bioavailability and also low toxicity (4). In one study, an inverse correlation was observed between the consumption of certain medicinal herbs, including sage and rosemary, and the incidence of lung cancer (5). In addition, traditional Chinese herbs have the characteristic of suppressing the expression of several genes involved in cancer (6). The inhibition of AKT expression is expected to interfere with the progression of cancer. We therefore hypothesized that certain medicinal herbs or spices affect the expression of AKT and therefore inhibit cell proliferation.

Materials and methods

Cell culture

The human cell lines K562, Daudi, Jurkat and U937 were maintained in RPMI-1640 supplemented with 10% fetal bovine serum (FBS), penicillin and streptomycin at 37°C in a humidified atmosphere containing 5% CO2.

Preparation of extracts and reagents

Herb and spice powders were purchased at a food market in Japan. The powders were dissolved in 80% ethanol and subsequently diluted in 40% ethanol at a stock concentration of 50 mg/ml. The mixtures were vortexed rigorously for 3 min followed by 3 min sonication. Following centrifugation at 1500 × g for 5 min, the supernatants were collected and stored at −20°C until use. The reagents used were dissolved in ethanol and subsequently diluted at a stock concentration of 10 mM. The reagents were stored at −20°C until use. For the cell treatments, a quantity of 0.5–10.0 μl was added into 1 ml of cell culture medium.

Reverse transcriptase polymerase chain reaction (RT-PCR)

Ubiquilin1, presenilin1 and GAPDH mRNAs were analyzed by semi-quantitative RT-PCR. Total RNA was extracted using an RNA isolation kit (Takara, Japan). Total RNA (2 μg)was reverse transcribed using a Phusion RT-PCR kit (New England Biolabs, Ipswich, MA, USA) as described in the manufacturer’s instructions. Cycle-based PCR was used to semi-quantitate the ubiquilin1 and presenilin1 gene level. GADPH was also used as an internal loading control. Samples were determined within 3 months of collection. The primers used for PCR were designed as follows: AKT1: forward, TCTATGGCGCTGAGATTGTG; and reverse, CTTAATGTGCCCGTCCTTGT (expected size, 116 bp); GAPDH: forward, TCCCATCACCATCTTCCA; and reverse, CATCACGCCACAGTTTCC (expected size, 376 bp). For real-time PCR, the reactions were performed in a real-time PCR system (Illumina, USA) using KAPA SYBR FAST reaction mix (Genetics, Japan). Thermocycling was performed according to the instructions at an annealing temperature of 60°C in a final volume of 10 μl including Taq DNA polymerase.

Western blot analysis

An equal amount of protein samples were used for western blot analysis using anti-AKT1 (Cell Signaling Technology, Inc.), anti-Rb2 (BD Transduction Laboratories) and anti-Erk2 (AnaSpec, Inc., Fremont, CA, USA) antibodies, and quantified by densitometry. Western blots were repeated at least three times and the representative data were shown.

Cell proliferation assay

Cell proliferation activity was examined using Tetra Color One (Seikagaku Corporation, Japan). Cells were seeded onto 96-well microplates (1,000 cells/well) and treated with extracts for 0, 24, 48, 72 and 96 h. Following treatment, Tetra Color One was added according to the manufacturer’s instructions. The optical density value of each well was measured using a microplate reader (BioRad iMark) with a test wavelength of 450 nm.

Cytotoxicity assay

Cytotoxicity was examined using Annexin V-EGFP (Abcam) and 7-AAD Red (Enzo Life Sciences, Inc.). These detection reagents were used according to the manufacturer’s instructions. Stained cells were detected by fluorescence microscopy (Eclipse Ti, Nikon).

Results and Discussion

Extracts of rosemary, green tea, sage, kuro-shitimi (red pepper), ginger, zingiber mioga or perilla frutescens were added into the cell culture media of the K562, Daudi, Jurkat or U937 cells, and the level of genes, including AKT1, was examined. RT-PCR analysis was employed to quantify the expression level of the gene. Total RNA was isolated 48 h after herbal extract treatment for the detection of AKT1, and the levels of mRNA were determined by conventional semi-quantitative RT-PCR (7). As shown in Fig. 1A, the AKT1 gene expression level was downregulated by the administration of sage or rosemary extracts at a final concentration of 50 μg/ml, compared with the control ethanol vehicle. Similar results were obtained from the quantitative real-time RT-PCR analysis (Fig. 1B). No product was amplified in the no-template sample or when reverse transcriptions were omitted. However, the expression of anti-oncogenes BRCA1, BRCA2, Rb1 and Rb2 (data not shown) and the housekeeping gene GAPDH was unaltered (Fig. 1B). Differences among the gene expression profiles of K562, Daudi, Jurkat and U937 cells were insignificant (data not shown).

To examine the expression status at the protein level, Western blot analysis was used to analyze the AKT1 protein in the cells stimulated by sage or rosemary. As shown in Fig. 2, the sage or rosemary extracts markedly reduced the protein expression of AKT1, but not Erk2, in K562 cells, when cell cultures had been maintained in the herb stimulation for 48 h. To rule out the possibility that sage or rosemary had any effects other than protein expression, we also checked several molecules relevant to cell proliferation. The expression of BRCA1, BRCA2, Rb1, Rb2 and Erk2 was then subjected to evaluation, since AKT1 affected the function of anti-oncogene products in cancer cells (8). We found that sage or rosemary extracts markedly enhanced the protein expression of Rb2 (Fig. 2, middle panel). Similar results were also obtained with BRCA2 (data not shown).

Notably, sage and rosemary did not function synergistically to reduce AKT1 expression in K562 and other cells (data not shown). We addressed the question of whether a component of sage or rosemary was capable of reducing AKT1 expression. The common components of sage and rosemary are linalool, carnosol and terpinolene; these are expected to have anti-proliferative ability (9,10). As shown in Fig. 3A, terpinolene markedly reduced the protein expression of AKT1; however, linalool or carnosol did not downregulate it. Following the treatment of the cells with various concentrations of terpinolene, western blot analysis revealed that the protein expression of AKT1, but not Erk2, was decreased with the increasing concentrations of terpinolene in the K562 and Jurkat cells (Fig. 3B). The final concentration of 0.05% terpinolene inhibited AKT1 expression by more than 95% in K562 and Jurkat cells (Fig. 3B). The chemical molecular structure of terpinolene is shown in Fig. 3C. It is produced by the alcoholic sulfuric acid treatment of pinene or by fractionation of turpentine.

The effect of sage or rosemary on cell proliferation activity was examined. The extracts were used in 3-day growth curves to determine the effects of cell proliferation. The assay revealed that cell proliferation activity was affected by sage or rosemary treatment in K562 cells, as shown in Fig. 4. Similar results were obtained with the use of Jurkat cells (data not shown). We again tested the effects of terpinolene on K562 cell proliferation activity and found that terpinolene significantly inhibited it (Fig. 4B). These results revealed the significant effect of terpinolene on K562 cell growth. We investigated whether terpinolene induced cytotoxicity in K562 cells. Results showed that terpinolene significantly induced cell apoptosis as much as staurosporine (Fig. 4C), unlike other molecules such as carnosol (data not shown).

The possibility of interactions between natural products and conventional prescription medicines is one of the most crucial issues in pharmacotherapeutic safety. Terpinolene is also used as a synthetic food flavoring additive or fragrance enhancer. Thus, it has high potential for human exposure. Although we have not yet identified the precise molecular mechanisms by which AKT1 expression is regulated, our findings provide new insight regarding cancer chemoprevention via the PI3K pathway and may help to establish strategies for a viable therapy.

Acknowledgements

This study was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology in Japan, and the Nara Women’s University Intramural Grant for Project Research. In addition, this study was supported in part by a grant from the Fuji Foundation for Protein Research.

References

1 

Castaneda CA, Cortes-Funes H, Gomez HL and Ciruelos EM: The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer. Cancer Metastasis Rev. 29:751–759. 2010.

2 

Martelli AM, Evangelisti C, Chiarini F, et al: The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. Biochim Biophys Acta. 1803:991–1002. 2010.

3 

Pal SK, Reckamp K, Yu H and Figurelin RA: Akt inhibitors in clinical development for the treatment of cancer. Expert Opin Investig Drugs. 19:1355–1366. 2010.

4 

Abad MJ, Bedoya LM and Bermejo P: An update on drug interactions with the herbal medicine Ginkgo biloba. Curr Drug Metab. 11:171–181. 2010.

5 

Johnson JJ: Carnosol: a promising anti-cancer and anti-inflammatory agent. Cancer Lett. 305:1–7. 2011.

6 

Liu CP, Tsai WJ, Lin YL, Liao JF, Chen CF and Kuo YC: The extracts from Nelumbo Nucifera suppress cell cycle progression, cytokine genes expression, and cell proliferation in human peripheral blood mononuclear cells. Life Sci. 75:699–716. 2004.

7 

Nishimura Y, Kitagishi Y, Yoshida H, Okumura N and Matsuda S: Ethanol extracts of black pepper or turmeric down-regulated SIRT1 protein expression in Daudi culture cells. Mol Med Report. 4:727–730. 2011.

8 

Plo I, Laulier C, Gauthier L, Lebrun F, Calvo F and Lopez BS: AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51. Cancer Res. 68:9404–9412. 2008.

9 

Cherng JM, Shieh DE, Chiang W, Chang MY and Chiang LC: Chemopreventive effects of minor dietary constituents in common foods on human cancer cells. Biosci Biotechnol Biochem. 71:1500–1504. 2007.

10 

Yoshida N, Takada T, Yamamura Y, Adachi I, Suzuki H and Kawakami J: Inhibitory effects of terpenoids on multidrug resistance-associated protein 2- and breast cancer resistance protein-mediated transport. Drug Metab Dispos. 36:1206–1211. 2008.

Journal Cover

February 2012
Volume 3 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

2013 Impact Factor: 0.987
Ranked #149/202 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation